| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18827604 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 107 journal articles in the PubMed database | Email to a friend | | |
| Kawada I, Soejima K, Watanabe H, et al.
An alternative method for screening EGFR mutation using RFLP in non-small cell lung cancer patients. [Journal Article]
J Thorac Oncol 2008 Oct; 3(10):1096-103.
Abstract | Full Citation | Find Related Articles | | Kimura H, Fujiwara Y, Sone T, et al.
EGFR mutation status in tumour-derived DNA from pleural effusion fluid is a practical basis for predicting the response to gefitinib. [JOURNAL ARTICLE]
Br J Cancer 2006 Oct 24.
Abstract | Full Citation | Find Related Articles | | Chou TY, Chiu CH, Li LH, et al.
Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancer. [Journal Article]
Clin Cancer Res 2005 May 15; 11(10):3750-7.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Sasaki H, Shimizu S, Endo K, et al.
EGFR and erbB2 mutation status in Japanese lung cancer patients. [Journal Article]
Int J Cancer 2006 Jan 1; 118(1):180-4.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Jänne PA, Borras AM, Kuang Y, et al.
A rapid and sensitive enzymatic method for epidermal growth factor receptor mutation screening. [Journal Article]
Clin Cancer Res 2006 Feb 1; 12(3 Pt 1):751-8.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Zhou CC, Zhou SW, Pan H, et al.
[Detection of epidermal growth factor receptor mutations in non-small cell lung cancer by real-time PCR using TaqMan-MGB probes.] [JOURNAL ARTICLE]
Zhonghua Zhong Liu Za Zhi 2007 Feb; 29(2):119-123.
Abstract | Full Citation | | Tomizawa Y, Iijima H, Sunaga N, et al.
Clinicopathologic significance of the mutations of the epidermal growth factor receptor gene in patients with non-small cell lung cancer. [Journal Article]
Clin Cancer Res 2005 Oct 1; 11(19 Pt 1):6816-22.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Argiris A, Hensing T, Yeldandi A, et al.
Combined analysis of molecular and clinical predictors of gefitinib activity in advanced non-small cell lung cancer: epidermal growth factor receptor mutations do not tell the whole story. [Journal Article, Research Support, Non-U.S. Gov't]
J Thorac Oncol 2006 Jan; 1(1):52-60.
Abstract | Full Citation | Find Related Articles | | Yoshida K, Yatabe Y, Park JY, et al.
Prospective Validation for Prediction of Gefitinib Sensitivity by Epidermal Growth Factor Receptor Gene Mutation in Patients with Non-Small Cell Lung Cancer. [JOURNAL ARTICLE]
J Thorac Oncol 2007 Jan; 2(1):22-28.
Abstract | Full Citation | Find Related Articles |   |
|
| |
Advertise on this site.
|
